News About: Pharm. Industry
Foreign multinational drug corporations made market breakthrough.
After implementation of the medical and pharmacy separation program the foreign multinational drug corporations have succeeded in infiltrating the market with their expensive original drugs.
According to Ya...
Bio-venture Enterprises, Requisite to KOSDAQ Registration Relaxed
The entrance sill of future enterprises like information telecommunication (IT) and environment technology (ET) including bio (BT) into KOSDAQ market becomes low.
Meanwhile, general enterprises' KOSDAQ registration...
Heo Young-sup, President at Green Cross Corp, Won Korea CEO Award
Heo Young-sup, president at Korea Green Cross Corp, won the second Korea CEO Award (at the department of medium enterprise) by Korea CEO society (president Park Gwang-seo, professor at SCH University) at the internati...
Drug company salesmen to equip with high-tech instruments.
"I am going out directly to work places without visit to the office every day. All orders and cash collection from the customers are made through my PDA (personal digital assistance)" said a salesman of pharmaceutical...
Domestic drug companies to activate development of bio-engineering products
To pave an advanced way for the forthcoming bio-tech era the domestic leading pharmaceutical companies are actively taking part in the R&D investment for the development of bio-engineering products in view of keeping...
Domestic Pharmaceutical Manufacturers Adjusted Export Amount Higher
Major pharmaceutical manufacturers in the country have a policy to devote all their energies to the export expansion strategy by exploiting new market this year, too.
According to this, they plan to substantially e...
BT Industry Created Triangular Axis of 'Conglomerate, Pharmaceutical Manufacturer and Venture'
It is expected that capacity will be collected for infra construction this year while conglomerate, pharmaceutical manufacturer, and bio-venture create triangular axis respectively in the local biology technology (BT)...
Construction of Clinical Experiment Infra is Urgent
Korea Pharmaceutical Manufacturers Association went out to make an urgent request for infra construction for the development of new medicines like establishing more clinical experimental institutes and epochal measure...
Recognition for Sales Job of Result Pay System Leaded to Change
Pharmaceutical manufacturing companies carry out the result pay system to boost morale and endow with motive for salesmen, and the recognition for them is changing as salesmen who received considerable result pay on t...
Kun Wha Pharmaceutical Co Diversified its Business by Taking Over Kukje Whajae
Kun Wha Pharmaceutical Co decided to take over Kukje Whajae, a nonlife insurance corporation.
Kun Wha Pharmaceutical Co held the board of directors on 9th and decided to take over Kukje Whajae, and bought fifty tho...
